# Ubiquiti Inc.: financial statements, quarterly UI · NYSE · CIK 1511737 · [Technology](/sectors/technology.md) · fiscal year ends Jun 30 Pages: [Overview](/companies/ui.md) · [Financials](/companies/ui/financials.md) · [Filings](/companies/ui/filings.md) · [Insiders](/companies/ui/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ui/financials.md?period=annual). ## Income statement | Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [463](/filings/0001511737-24-000078.md) | [465](/filings/0001511737-25-000013.md) | [493](/filings/0001511737-25-000033.md) | [507 d](/filings/0001511737-26-000056.md) | [550](/filings/0001511737-25-000076.md) | [600](/filings/0001511737-26-000014.md) | [664](/filings/0001511737-26-000034.md) | [759 d](/filings/0001511737-26-000056.md) | [734](/filings/0001511737-25-000076.md) | [815](/filings/0001511737-26-000014.md) | [788](/filings/0001511737-26-000034.md) | [937 d](/filings/0001511737-26-000056.md) | | Cost of revenue | $m | [279](/filings/0001511737-24-000078.md) | [287](/filings/0001511737-25-000013.md) | [319](/filings/0001511737-25-000033.md) | [303 d](/filings/0001511737-26-000056.md) | [319](/filings/0001511737-25-000076.md) | [353](/filings/0001511737-26-000014.md) | [368](/filings/0001511737-26-000034.md) | [416 d](/filings/0001511737-26-000056.md) | [396](/filings/0001511737-25-000076.md) | [441](/filings/0001511737-26-000014.md) | [417](/filings/0001511737-26-000034.md) | [508 d](/filings/0001511737-26-000056.md) | | Gross profit | $m | [184](/filings/0001511737-24-000078.md) | [178](/filings/0001511737-25-000013.md) | [174](/filings/0001511737-25-000033.md) | [204 d](/filings/0001511737-26-000056.md) | [232](/filings/0001511737-25-000076.md) | [247](/filings/0001511737-26-000014.md) | [296](/filings/0001511737-26-000034.md) | [343 d](/filings/0001511737-26-000056.md) | [337](/filings/0001511737-25-000076.md) | [374](/filings/0001511737-26-000014.md) | [371](/filings/0001511737-26-000034.md) | [429 d](/filings/0001511737-26-000056.md) | | Research and development | $m | [36.3](/filings/0001511737-24-000078.md) | [36.9](/filings/0001511737-25-000013.md) | [42.5](/filings/0001511737-25-000033.md) | [44.1 d](/filings/0001511737-26-000056.md) | [38.0](/filings/0001511737-25-000076.md) | [40.0](/filings/0001511737-26-000014.md) | [44.3](/filings/0001511737-26-000034.md) | [47.5 d](/filings/0001511737-26-000056.md) | [48.5](/filings/0001511737-25-000076.md) | [50.8](/filings/0001511737-26-000014.md) | [51.8](/filings/0001511737-26-000034.md) | [53.0 d](/filings/0001511737-26-000056.md) | | Selling, general and administrative | $m | [19.3](/filings/0001511737-24-000078.md) | [19.6](/filings/0001511737-25-000013.md) | [20.4](/filings/0001511737-25-000033.md) | [21.7 d](/filings/0001511737-26-000056.md) | [24.4](/filings/0001511737-25-000076.md) | [28.5](/filings/0001511737-26-000014.md) | [24.8](/filings/0001511737-26-000034.md) | [33.9 d](/filings/0001511737-26-000056.md) | [27.1](/filings/0001511737-25-000076.md) | [30.3](/filings/0001511737-26-000014.md) | [28.1](/filings/0001511737-26-000034.md) | [36.3 d](/filings/0001511737-26-000056.md) | | Operating income | $m | [128](/filings/0001511737-24-000078.md) | [121](/filings/0001511737-25-000013.md) | [111](/filings/0001511737-25-000033.md) | [138 d](/filings/0001511737-26-000056.md) | [169](/filings/0001511737-25-000076.md) | [179](/filings/0001511737-26-000014.md) | [227](/filings/0001511737-26-000034.md) | [261 d](/filings/0001511737-26-000056.md) | [262](/filings/0001511737-25-000076.md) | [293](/filings/0001511737-26-000014.md) | [291](/filings/0001511737-26-000034.md) | [340 d](/filings/0001511737-26-000056.md) | | Income tax | $m | [19.3](/filings/0001511737-24-000078.md) | [20.7](/filings/0001511737-25-000013.md) | [16.1](/filings/0001511737-25-000033.md) | [17.8 d](/filings/0001511737-26-000056.md) | [30.6](/filings/0001511737-25-000076.md) | [30.6](/filings/0001511737-26-000014.md) | [41.0](/filings/0001511737-26-000034.md) | [(8.5) d](/filings/0001511737-26-000056.md) | [50.7](/filings/0001511737-25-000076.md) | [57.7](/filings/0001511737-26-000014.md) | [56.2](/filings/0001511737-26-000034.md) | [58.2 d](/filings/0001511737-26-000056.md) | | Net income | $m | [87.8](/filings/0001511737-25-000033.md) | [82.1](/filings/0001511737-25-000033.md) | [76.3](/filings/0001511737-25-000033.md) | [104 d](/filings/0001511737-26-000056.md) | [128](/filings/0001511737-26-000034.md) | [137](/filings/0001511737-26-000034.md) | [180](/filings/0001511737-26-000034.md) | [267 d](/filings/0001511737-26-000056.md) | [208](/filings/0001511737-26-000034.md) | [234](/filings/0001511737-26-000034.md) | [234](/filings/0001511737-26-000034.md) | [285 d](/filings/0001511737-26-000056.md) | | Diluted EPS | $ per share | [1.45](/filings/0001511737-24-000078.md) | [1.36](/filings/0001511737-25-000013.md) | [1.26](/filings/0001511737-25-000033.md) | not reported | [2.12](/filings/0001511737-25-000076.md) | [2.26](/filings/0001511737-26-000014.md) | [2.98](/filings/0001511737-26-000034.md) | not reported | [3.43](/filings/0001511737-25-000076.md) | [3.86](/filings/0001511737-26-000014.md) | [3.86](/filings/0001511737-26-000034.md) | not reported | | Basic EPS | $ per share | [1.45](/filings/0001511737-24-000078.md) | [1.36](/filings/0001511737-25-000013.md) | [1.26](/filings/0001511737-25-000033.md) | not reported | [2.12](/filings/0001511737-25-000076.md) | [2.26](/filings/0001511737-26-000014.md) | [2.98](/filings/0001511737-26-000034.md) | not reported | [3.44](/filings/0001511737-25-000076.md) | [3.86](/filings/0001511737-26-000014.md) | [3.87](/filings/0001511737-26-000034.md) | not reported | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [109](/filings/0001511737-23-000082.md) | [97.6](/filings/0001511737-24-000010.md) | [102](/filings/0001511737-24-000027.md) | [126](/filings/0001511737-25-000053.md) | [165](/filings/0001511737-24-000078.md) | [133](/filings/0001511737-25-000013.md) | [151](/filings/0001511737-25-000033.md) | [150](/filings/0001511737-26-000056.md) | [177](/filings/0001511737-25-000076.md) | [303](/filings/0001511737-26-000014.md) | [369](/filings/0001511737-26-000034.md) | [523](/filings/0001511737-26-000056.md) | | Current assets | $m | [1,154](/filings/0001511737-23-000082.md) | [1,106](/filings/0001511737-24-000010.md) | [1,001](/filings/0001511737-24-000027.md) | [916](/filings/0001511737-25-000053.md) | [926](/filings/0001511737-24-000078.md) | [962](/filings/0001511737-25-000013.md) | [1,082](/filings/0001511737-25-000033.md) | [1,173](/filings/0001511737-26-000056.md) | [1,200](/filings/0001511737-25-000076.md) | [1,293](/filings/0001511737-26-000014.md) | [1,404](/filings/0001511737-26-000034.md) | [1,834](/filings/0001511737-26-000056.md) | | Total assets | $m | [1,388](/filings/0001511737-23-000082.md) | [1,335](/filings/0001511737-24-000010.md) | [1,224](/filings/0001511737-24-000027.md) | [1,154](/filings/0001511737-25-000053.md) | [1,158](/filings/0001511737-24-000078.md) | [1,184](/filings/0001511737-25-000013.md) | [1,298](/filings/0001511737-25-000033.md) | [1,466](/filings/0001511737-26-000056.md) | [1,490](/filings/0001511737-25-000076.md) | [1,608](/filings/0001511737-26-000014.md) | [1,715](/filings/0001511737-26-000034.md) | [2,198](/filings/0001511737-26-000056.md) | | Current liabilities | $m | [338](/filings/0001511737-23-000082.md) | [288](/filings/0001511737-24-000010.md) | [254](/filings/0001511737-24-000027.md) | [285](/filings/0001511737-25-000053.md) | [364](/filings/0001511737-24-000078.md) | [432](/filings/0001511737-25-000013.md) | [779](/filings/0001511737-25-000033.md) | [711](/filings/0001511737-26-000056.md) | [573](/filings/0001511737-25-000076.md) | [476](/filings/0001511737-26-000014.md) | [394](/filings/0001511737-26-000034.md) | [627](/filings/0001511737-26-000056.md) | | Total liabilities | $m | [1,451](/filings/0001511737-23-000082.md) | [1,351](/filings/0001511737-24-000010.md) | [1,198](/filings/0001511737-24-000027.md) | [1,059](/filings/0001511737-25-000053.md) | [970](/filings/0001511737-24-000078.md) | [893](/filings/0001511737-25-000013.md) | [862](/filings/0001511737-25-000033.md) | [798](/filings/0001511737-26-000056.md) | [662](/filings/0001511737-25-000076.md) | [593](/filings/0001511737-26-000014.md) | [513](/filings/0001511737-26-000034.md) | [758](/filings/0001511737-26-000056.md) | | Long-term debt | $m | [1,007](/filings/0001511737-23-000082.md) | [958](/filings/0001511737-24-000010.md) | [839](/filings/0001511737-24-000027.md) | [670](/filings/0001511737-25-000053.md) | [527](/filings/0001511737-24-000078.md) | [381](/filings/0001511737-25-000013.md) | [0.0](/filings/0001511737-25-000033.md) | [0.0](/filings/0001511737-25-000053.md) | [134](/filings/0001511737-25-000076.md) | [47.5](/filings/0001511737-26-000014.md) | not reported | not reported | | Short-term borrowings | $m | [36.5](/filings/0001511737-23-000082.md) | [36.5](/filings/0001511737-24-000010.md) | [36.5](/filings/0001511737-24-000027.md) | [36.5](/filings/0001511737-25-000053.md) | [24.4](/filings/0001511737-24-000078.md) | [24.4](/filings/0001511737-25-000013.md) | [339](/filings/0001511737-25-000033.md) | [250](/filings/0001511737-26-000056.md) | [133](/filings/0001511737-25-000076.md) | [47.4](/filings/0001511737-26-000014.md) | [0.0](/filings/0001511737-26-000034.md) | [0.0](/filings/0001511737-26-000056.md) | | Shareholders' equity | $m | [(63.1)](/filings/0001511737-25-000033.md) | [(15.7)](/filings/0001511737-25-000033.md) | [25.9](/filings/0001511737-25-000033.md) | [95.1](/filings/0001511737-26-000056.md) | [188](/filings/0001511737-26-000034.md) | [290](/filings/0001511737-26-000034.md) | [436](/filings/0001511737-26-000034.md) | [668](/filings/0001511737-26-000056.md) | [828](/filings/0001511737-26-000034.md) | [1,016](/filings/0001511737-26-000034.md) | [1,202](/filings/0001511737-26-000034.md) | [1,440](/filings/0001511737-26-000056.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt - Short-term borrowings: us-gaap:ShortTermBorrowings - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [67.7](/filings/0001511737-24-000078.md) | [78.6 d](/filings/0001511737-25-000013.md) | [164 d](/filings/0001511737-25-000033.md) | [231 d](/filings/0001511737-26-000056.md) | [234](/filings/0001511737-25-000076.md) | [152 d](/filings/0001511737-26-000014.md) | [124 d](/filings/0001511737-26-000034.md) | [130 d](/filings/0001511737-26-000056.md) | [198](/filings/0001511737-25-000076.md) | [264 d](/filings/0001511737-26-000014.md) | [168 d](/filings/0001511737-26-000034.md) | [299 d](/filings/0001511737-26-000056.md) | | Capital expenditure | $m | [3.0](/filings/0001511737-24-000078.md) | [3.9 d](/filings/0001511737-25-000013.md) | [3.2 d](/filings/0001511737-25-000033.md) | [1.9 d](/filings/0001511737-26-000056.md) | [2.6](/filings/0001511737-25-000076.md) | [2.0 d](/filings/0001511737-26-000014.md) | [2.8 d](/filings/0001511737-26-000034.md) | [5.2 d](/filings/0001511737-26-000056.md) | [5.2](/filings/0001511737-25-000076.md) | [3.6 d](/filings/0001511737-26-000014.md) | [5.6 d](/filings/0001511737-26-000034.md) | [5.4 d](/filings/0001511737-26-000056.md) | | Dividends paid | $m | [36.3](/filings/0001511737-24-000078.md) | [36.3 d](/filings/0001511737-25-000013.md) | [36.3 d](/filings/0001511737-25-000033.md) | [36.3 d](/filings/0001511737-26-000056.md) | [36.3](/filings/0001511737-25-000076.md) | [36.3 d](/filings/0001511737-26-000014.md) | [36.3 d](/filings/0001511737-26-000034.md) | [36.3 d](/filings/0001511737-26-000056.md) | [48.4](/filings/0001511737-25-000076.md) | [48.4 d](/filings/0001511737-26-000014.md) | [48.4 d](/filings/0001511737-26-000034.md) | [48.4 d](/filings/0001511737-26-000056.md) | | Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividends - Share repurchases: not reported ## Shares | Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [60.4](/filings/0001511737-23-000082.md) | [60.4](/filings/0001511737-24-000010.md) | [60.5](/filings/0001511737-24-000027.md) | [60.5](/filings/0001511737-24-000078.md) | [60.5](/filings/0001511737-25-000013.md) | [60.5](/filings/0001511737-25-000033.md) | [60.5](/filings/0001511737-25-000076.md) | [60.5](/filings/0001511737-26-000014.md) | [60.5](/filings/0001511737-26-000034.md) | [60.6](/filings/0001511737-25-000076.md) | [60.6](/filings/0001511737-26-000014.md) | [60.6](/filings/0001511737-26-000034.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 60,528,381 at 2026-08-20, from the cover of the [10-K filed 2026-08-21](/filings/0001511737-26-000056.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.